Improvement and influencing factors of blood pressure control by nephrologist referral in chronic kidney disease patients in China: a cohort study

被引:4
|
作者
Wang, Li-Yan [1 ]
Yin, Dao-Xin [1 ]
Zhang, Dong-Liang [1 ]
Xu, Rui [1 ]
Cui, Wen-Ying [1 ]
Liu, Wen-Hu [1 ]
机构
[1] Capital Med Univ, Fac Kidney Dis, Affiliated Beijing Friendship Hosp, Dept Nephrol, Beijing 100050, Peoples R China
关键词
Chronic kidney disease; Hypertension; Blood pressure control; Antihypertensive treatment; SYSTOLIC HYPERTENSION; CARDIOVASCULAR EVENTS; ARTERIAL STIFFNESS; MANAGEMENT; PREVALENCE; TARGET; RISK; ALBUMINURIA; PROTEINURIA; PROTECTION;
D O I
10.1007/s11255-012-0332-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is an independent risk factor for mortality in chronic kidney disease (CKD) and is suboptimally controlled worldwide. Therefore, this study aimed to examine the rate of BP control and the main barriers to achieving target BP, according to K/DOQI guidelines, in China. We performed a single-center, prospective cohort study. Two hundred and sixty CKD patients were referred by general physicians to nephrologists, and their BP was treated in accordance with K/DOQI guidelines for a 1-year follow-up. We evaluated improvement of BP target achievement and factors affecting BP control. We defined "not-at-goal" as persistence of systolic BP a parts per thousand yen 130 mmHg and/or diastolic BP a parts per thousand yen 80 mmHg after 1 year. The BP decreased from 138 +/- A 12/84 +/- A 7 mmHg at baseline to 124 +/- A 13/73 +/- A 7 mmHg after 1 year. The rate of achieving the BP goal (< 130/80 mmHg) increased from 25.4 to 61.5 %. The decrease in BP was associated with a significant reduction of proteinuria (median, 0.14 vs 0.06 g/24 h; P < 0.05). Logistic regression analysis identified proteinuria levels a parts per thousand yen1.0 g/24 h (odds ratio [OR]: 5.21; 95 % confidence interval [CI]: 1.37-19.77) and high basal systolic BP (OR: 2.17; 95 % CI: 1.25-3.77) and diastolic BP (OR: 6.62; 95 % CI: 2.03-21.60) as independent predictors of not-at-goal BP. Higher educational level was independently associated with at-goal BP (OR: 0.21; 95 % CI: 0.06-0.78). In CKD patients, BP control is poor when managed by general physicians and may be improved after nephrologist referral. High basal BP and proteinuria levels a parts per thousand yen1.0 g/24 h are the main barriers that preclude the optimal control of BP.
引用
收藏
页码:1345 / 1353
页数:9
相关论文
共 50 条
  • [31] Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study
    Lee, You-Bin
    Lee, Ji Sung
    Hong, So-hyeon
    Kim, Jung A.
    Roh, Eun
    Yoo, Hye Jin
    Baik, Sei Hyun
    Choi, Kyung Mook
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [32] Effect of antitubercular medications on blood pressure control in chronic kidney disease patients with tuberculosis: a prospective cohort study
    Sharma, Ajay P.
    Sural, Saubhik
    Gupta, Amit
    Garg, Amit X.
    Gulati, Sanjeev
    Sharma, Raj K.
    JOURNAL OF NEPHROLOGY, 2006, 19 (06) : 771 - 777
  • [33] Factors Affecting the Referral Time to Nephrologists in Patients With Chronic Kidney Disease: A Prospective Cohort Study in Korea
    Lee, Jeonghwan
    Lee, Jung Pyo
    An, Jung Nam
    Kim, Sung Gyun
    Kim, Yong-Lim
    Yang, Chul Woo
    Kang, Shin-Wook
    Kim, Nam-Ho
    Kim, Yon Su
    Oh, Yun Kuy
    Lim, Chun Soo
    MEDICINE, 2016, 95 (19)
  • [34] Referral, monitoring, and factors associated with non-referral of chronic kidney disease in Germany: a nationwide, retrospective cohort study
    von Samson-Himmelstjerna, Friedrich A.
    Steiger, Edgar
    Kolbrink, Benedikt
    Wulfrath, Hauke S.
    Czihal, Thomas
    Schmitt, Roland
    von Stillfried, Dominik
    Schulte, Kevin
    LANCET REGIONAL HEALTH-EUROPE, 2024, 47
  • [35] Tight Blood Pressure Control in Chronic Kidney Disease
    Gentile, Giorgio
    Mckinney, Kathryn
    Reboldi, Gianpaolo
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (05)
  • [36] Effects of intensive blood pressure control on mortality and cardiorenal function in chronic kidney disease patients
    Zhang, Yong
    Li, Jing-Jing
    Wang, An-Jun
    Wang, Bo
    Hu, Shou-Liang
    Zhang, Heng
    Li, Tian
    Tuo, Yan-Hong
    RENAL FAILURE, 2021, 43 (01) : 811 - 820
  • [37] Systolic Blood Pressure and Outcomes in Stage 3-4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort
    Chiang, Heng-Pin
    Lee, Jia-Jung
    Chiu, Yi-Wen
    Tsai, Jer-Chia
    Hung, Chi-Chih
    Hwang, Shang-Jyh
    Chen, Hung-Chun
    AMERICAN JOURNAL OF HYPERTENSION, 2014, 27 (11) : 1396 - 1407
  • [38] Adherence to Antihypertensive Agents and Blood Pressure Control in Chronic Kidney Disease
    Schmitt, Kristen E.
    Edie, Christine F.
    Laflam, Paul
    Simbartl, Loretta A.
    Thakar, Charuhas V.
    AMERICAN JOURNAL OF NEPHROLOGY, 2010, 32 (06) : 541 - 548
  • [39] STRATEGIES FOR CONTROLLING BLOOD PRESSURE AND REDUCING CARDIOVASCULAR DISEASE RISK IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Norris, Keith C.
    Nicholas, Susanne B.
    ETHNICITY & DISEASE, 2015, 25 (04) : 515 - 520
  • [40] Referral rate of chronic kidney disease patients to a nephrologist in the Region of Southern Denmark: results from KidDiCo
    Kampmann, Jan Dominik
    Heaf, James Goya
    Mogensen, Christian Backer
    Mickley, Hans
    Wolff, Donna Lykke
    Brandt, Frans
    CLINICAL KIDNEY JOURNAL, 2022, 15 (11) : 2116 - 2123